Table 2.
Therapy | Baseline (% of Normal) |
Dystrophin Production (% of Normal) |
Side Effects |
---|---|---|---|
Eteplirsen [44] | 0.08 | 0.93 | No severe or moderate adverse events 8 mild events considered related to treatment [45] |
Golodirsen [46] | 0.095 | 1.019 | 2 moderate adverse events (infection and pyrexia) 8 mild events considered related to treatment |
Viltolarsen [43] | 0.3 (dose of 40 mg/kg) 0.6 (dose of 80 mg/kg) |
5.7 (dose of 40 mg/kg) 5.9 (dose of 80 mg/kg) |
No severe or moderate adverse events No mild events considered related to treatment |